---
schema_version: "secwatch.filing_event.v1"
accession: "0000021076-23-000013"
form_type: "8-K"
ticker: "CLX"
cik: "0000021076"
company_name: "CLOROX CO /DE/"
filed_at: "2023-05-02T23:59:59+00:00"
generated_at: "2026-06-16T03:53:13.853988+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Clorox Q3 FY2023: adj EPS +15%, net sales +6%, raises full-year outlook

## Summary
- Net sales $1.91B (+6% YoY); organic sales +8%; gross margin 41.8% (+590 bps).
- Adjusted EPS $1.51 (+15% YoY); GAAP diluted EPS loss $1.71 due to $445M impairment in vitamins.
- YTD operating cash flow $728M, up 61% YoY; free cash flow $584M, 10.9% of sales.
- Health & Wellness segment volume -16% but price/mix +23%; Lifestyle sales +15%.
- Company raises FY2023 outlook citing pricing, cost savings, and strategic investments.

## SEC filing metadata
- accession: 0000021076-23-000013
- form_type: 8-K
- ticker: CLX
- cik: 0000021076
- company_name: CLOROX CO /DE/
- filed_at: 2023-05-02T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/21076/000002107623000013/0000021076-23-000013-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/21076/000002107623000013/clx-20230502.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000021076-23-000013
- JSON: https://secwatch.observer/filing/0000021076-23-000013.json
- Plain text: https://secwatch.observer/filing/0000021076-23-000013.txt

## Key facts
- Earnings Releases
  CLOROX CO /DE/ reported third quarter ended March 31, 2023 results: revenue $1.91 billion, EPS (a noncash impairment charge of $445 million ($362 million after tax or $2.92) ...). Guidance raised.
  - Period: third quarter ended March 31, 2023
  - Revenue: $1.91 billion
  - EPS: (a noncash impairment charge of $445 million ($362 million after tax or $2.92) ...)
  - Guidance: raised
  - Result: reported results
  source text: Summary Following is a summary of key third-quarter results. All comparisons are with the third quarter of fiscal year 2022 unless otherwise stated. • Net sales increased 6% to $1.91 billion compared to a 2% net sales increase in the year-ago quarter. The net sales increase was driven largely by favorable price mix, partially offset by lower volume. Organic sales 1
  evidence_url: https://www.sec.gov/Archives/edgar/data/21076/000002107623000013/0000021076-23-000013-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.